Assentfarma SA
0.3 FTEThe score of Assentfarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +35 % Total assets +15 % Headcount (avg FTE) -67 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Assentfarma's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 136,937 € | ||||
| Equity | 831,368 € | ||||
| Cash | 357,650 € | ||||
| EBITDA | 181,627 € | ||||
| Total assets | €1.08m |
Filed annual accounts
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 28 May 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
- Year ended 31 Dec 2020filed on 12 Jul 2021
Assentfarma's financial analysis
- Solvency76.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Assentfarma
Assentfarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.449.350
- VAT number
- BE0476449350
- Peppol
- Registered · 0208:0476449350 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 04 Jan 2002
- Registered office
- 3460 Bekkevoort
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2024 · filed on 12 Jun 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Assentfarma (SA) has been based in Bekkevoort since 2002, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 136,937 € and equity of 831,368 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 76.9%, above the median of its sector (44.2%).
Companies similar to Assentfarma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Dewaele - IDE Retail sale of pharmaceutical products Kortrijk · balance sheet €1.08m
- Pharmacie Dufrasne Retail sale of pharmaceutical products Nivelles · balance sheet €1.08m
- Ap. Pharmamax Retail sale of pharmaceutical products Boom · balance sheet €1.09m
- Stediphar Retail sale of pharmaceutical products Ostend · balance sheet €1.09m
- P. Corstiens Farma Retail sale of pharmaceutical products Westerlo · balance sheet €1.09m
- Fardil Retail sale of pharmaceutical products Dilbeek · balance sheet €1.10m
- DE Maeyer Retail sale of pharmaceutical products Dilbeek · balance sheet €1.07m
- Holsbeek Brasschaat Retail sale of pharmaceutical products Brasschaat · balance sheet €1.10m
Frequently asked questions about Assentfarma
What is the revenue of Assentfarma?
Assentfarma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Assentfarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0476449350 for Assentfarma, if the company is VAT-registered. Its company number (CBE) is 0476.449.350.
Where is the registered office of Assentfarma?
According to the CBE register, the registered office of Assentfarma is in 3460 Bekkevoort.
What is the equity of Assentfarma?
At the close of the 2024 financial year, the equity of Assentfarma amounts to 831,368 €, a solvency of 76.9% of total assets.
How many people work at Assentfarma?
0.3 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Assentfarma?
The register lists 3 active mandates at Assentfarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Assentfarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →